MY.Alpha Management HK Advisors’s Vicarious Surgical RBOT Stock Holding History

MY.Alpha Management HK Advisors’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-34,390	Closed	-$189K	–	14
2025 Q3	$189K	Sell	34,390 -107,498	-76%	-$822K	0.12%	11
2025 Q2	$1.06M	Sell	141,888 -16,056	-10%	-$117K	0.79%	14
2025 Q1	$1.04M	Sell	157,944 -24,491	-13%	-$289K	0.52%	18
2024 Q4	$2.4M	Hold	182,435	–	–	1.06%	17
2024 Q3	$1.04M	Sell	182,435 -24,900	-12%	-$165K	0.37%	14
2024 Q2	$1.22M	Sell	207,335 -1	-0%	-$9	0.46%	16
2024 Q1	$1.88M	Sell	207,336 -38,733	-16%	-$462K	0.7%	14
2023 Q4	$2.71M	Buy	246,069 +144,443	+142%	+$1.61M	1.4%	11
2023 Q3	$5.58M	Hold	101,626	–	–	2.53%	10
2023 Q2	$5.58M	Hold	101,626	–	–	2.53%	10
2023 Q1	$6.92M	Hold	101,626	–	–	2.24%	12
2022 Q4	$6.16M	Buy	+101,626	New	+$9.45M	2.1%	12

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

MAM

Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return

MY.Alpha Management HK Advisors's RBOT Position: Q4 2025 in Review

MY.Alpha Management HK Advisors sold out of Vicarious Surgical (RBOT) in Q4 2025, closing a stake of 34,390 shares — an estimated $189K sold.

MY.Alpha Management HK Advisors first reported a position in RBOT in Q4 2022 and held it in 12 quarters. The position peaked at $6.92M in Q1 2023. 36 funds tracked by Wall St. Rank hold RBOT as of Q4 2025.

MY.Alpha Management HK Advisors reported no remaining Vicarious Surgical position as of Q4 2025 after selling out during the quarter.
MY.Alpha Management HK Advisors sold 34,390 Vicarious Surgical shares in Q4 2025, an estimated $189K.
MY.Alpha Management HK Advisors first reported a position in Vicarious Surgical in Q4 2022 and held it in 12 quarters.
MY.Alpha Management HK Advisors's Vicarious Surgical position peaked at $6.92M in Q1 2023.
36 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2025.

Based on MY.Alpha Management HK Advisors's 13F filing for Q4 2025, filed 10 Mar 2026.